Isabel Vallcorba

Dr. Isabel Vallcorba

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 1998 in Cytometry
Verified
Journal Article
Open access
PDF file
NMNorberto Malpica
Norberto Malpica
CSCarlos Ortiz De Solórzano
Carlos Ortiz De Solórzano
JVJuan José Vaquero
Juan José Vaquero
ASAndres Santos
Andres Santos
IVIsabel Vallcorba
Isabel Vallcorba
FPFrancisco del Pozo
Francisco del Pozo
Cluster division is a critical issue in fluorescence microscopy-based analytical cytology when preparation protocols do not provide appropriate separation of objects. Overlooking clustered nuclei and analyzing only isolated nuclei may dramatically increase analysis time or affect the statistical validation of the results. Automatic segmentation of clustered nuclei requires the implementation of specific image segmentation tools. Most algorithms are inspired by one of the two following strategies: 1) cluster division by the detection of internuclei gradients; or 2) division by definition of domains of influence (geometrical approach). Both strategies lead to completely different implementations, and usually algorithms based on a single view strategy fail to correctly segment most clustered nuclei, or perform well just for a specific type of sample. An algorithm based on morphological watersheds has been implemented and tested on the segmentation of microscopic nuclei clusters. This algorithm provides a tool that can be used for the implementation of both gradient- and domain-based algorithms, and, more importantly, for the implementation of mixed (gradient- and shape-based) algorithms. Using this algorithm, almost 90% of the test clusters were correctly segmented in peripheral blood and bone marrow preparations. The algorithm was valid for both types of samples, using the appropriate markers and transformations. Cytometry 28:289–297, 1997.

1 October 2017 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
LFLucía Fernández
Lucía Fernández
JMJean-Yves Metais
Jean-Yves Metais
AEAdela Escudero
Adela Escudero
MVMaría Vela
María Vela
JVJaime Valentín
Jaime Valentín
Antonio Pérez MartínezAntonio Pérez Martínez
Antonio Pérez Martínez
Purpose: NKG2D ligands (NKG2DL) are expressed on various tumor types and immunosuppressive cells within tumor microenvironments, providing suitable targets for cancer therapy. Various immune cells express NKG2D receptors, including natural killer (NK) cells and CD8+ T cells. Interactions between NKG2DL and NKG2D receptors are essential for NK-cell elimination of osteosarcoma tumor-initiating cells. In this report, we used NKG2D–NKG2DL interactions to optimize an immunotherapeutic strategy against osteosarcoma. We evaluated in vitro and in vivo the safety and cytotoxic capacity against osteosarcoma cells of CD45RA− memory T cells expressing an NKG2D-4-1BB-CD3z chimeric antigen receptor (CAR). Experimental Design: CD45RA− cells from healthy donors were transduced with NKG2D CARs containing 4-1BB and CD3z signaling domains. NKG2D CAR expression was analyzed by flow cytometry. In vitro cytotoxicity of NKG2D-CAR+ CD45RA− T cells against osteosarcoma was evaluated by performing conventional 4-hour europium-TDA release assays. For the in vivo orthotopic model, 531MII YFP-luc osteosarcoma cells were used as targets in NOD-scid IL2Rgnull mice. Results: Lentiviral transduction of NKG2D-4-1BB-CD3z markedly increased NKG2D surface expression in CD45RA− cells. Genetic stability was preserved in transduced cells. In vitro, NKG2D-CAR+ memory T cells showed significantly increased cytolytic activity than untransduced cells against osteosarcoma cell lines, while preserving the integrity of healthy cells. NKG2D-CAR+ memory T cells had considerable antitumor activity in a mouse model of osteosarcoma, whereas untransduced T cells were ineffective. Conclusions: Our results demonstrate NKG2D-4-1BB-CD3z CAR–redirected memory T cells target NKG2DL-expressing osteosarcoma cells in vivo and in vitro and could be a promising immunotherapeutic approach for patients with osteosarcoma. Clin Cancer Res; 23(19); 5824–35. ©2017 AACR.

24 April 2006 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
IPI. López Pajares
I. López Pajares
OVO. Villa
O. Villa
MSM. Salido
M. Salido
MMM. A. Mori
M. A. Mori
AGA. Gonzalez
A. Gonzalez
ADA. Delicado
A. Delicado

1 February 1998 in Cytometry
Verified
Journal Article
Open access
PDF file
IVIsabel Vallcorba
Isabel Vallcorba
FPFrancisco del Pozo
Francisco del Pozo
CSCarlos Ortiz De Solórzano
Carlos Ortiz De Solórzano
ASAndres Santos
Andres Santos
JGJosé‐Miguel García‐Sagredo
José‐Miguel García‐Sagredo
The evaluation of an automated system for Fluorescence In Situ Hybridization (FISH) spot counting in interphase nuclei is presented in this paper. Different types of experiments have been performed with samples from known populations. In all of them the goal is to detect mosaicism of chromosome X in leukocytes from mixtures in known proportions of healthy male and female blood. First the initial results from the automatic FISH analysis system were obtained and evaluated. Then the analysis was modified to reduce systematic errors, so that the results are closer to what an experienced human operator would have obtained (system calibration step). Finally, an additional control probe of chromosome Y was used to detect and discard cells where incorrect hybridization or other abnormal situations had occurred. In each step the system sensitivity was determined by the use of two statistical validation tests, so that the improvement brought about by the correction methods could be assessed. The results obtained in the study showed that, using both corrections, the system is able to detect 10% monosomies with a significance level α = 0.1%. Cytometry 31:93–99, 1998.

18 January 2013 in Leukemia Research
Verified
Journal Article
Closed access
VAVera Ademà
Vera Ademà
Jesús María Hernández-RivasJesús María Hernández-Rivas
Jesús María Hernández-Rivas
MAMaría Abáigar
María Abáigar
ELEva Lumbreras
Eva Lumbreras
ESEsperanza Such
Esperanza Such
FRANCESC SOLEFRANCESC SOLE
FRANCESC SOLE

1 September 2013 in Revista Española de Enfermedades Digestivas
Verified
Journal Article
Open access
PDF file
MFMaría Jesús Fernández-Cavada-Pollo
María Jesús Fernández-Cavada-Pollo
MAMaría Inmaculada Alcalá-Peña
María Inmaculada Alcalá-Peña
MVMaría Luisa Vargas-Pérez
María Luisa Vargas-Pérez
EVEsther Vergara-Prieto
Esther Vergara-Prieto
IVIsabel Vallcorba
Isabel Vallcorba
CGCristina González-Roiz
Cristina González-Roiz
Background and objectives:celiac disease is associated with the HLA class II alleles: DQA1*05-DQB1*02 and DQB1*0302. The genetic risk for celiac disease may depend on the presence or absence of such alleles, their combination or number of copies. This study aimed to establish the differences in HLA genotypes between celiac patients diagnosed during childhood and adulthood, and between patients and healthy controls, and to determine the risk of disease in each genotypic category. Methods: we classified 350 celiac patients at time of diagnosis and 218 controls into 14 categories according to their HLA genotype, based on the presence or absence of risk alleles. Results: we found statistically significant differences between the genotype frequencies of celiac patients diagnosed as being children and adults. DQA1*05 (x 1 copy), DQB1*02 (x 1 copy), DQB1*0302 (x 0 copies) was the most frequent genotype in individuals diagnosed in childhood, whereas DQA1*05 (x 1 copy), DQB1*02 (x 2 copies), DQB1*0302 (x 0 copies) was the most frequent in adults. The risk for disease in each genotypic category in celiac children and adults turned out to be different. The presence of DQB1*0302 did not increase risk in children, but did in adults. Conclusion: in our celiac population, we found a different genetic pattern according to age of diagnosis. That could suggest that the pathogenic mechanism of the disease is not exactly the same in both age groups, which could somehow determine clinical presentation of the disease, its epidemiology, coexisting diseases, and complications